{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:15:56Z","timestamp":1790306156312,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.jaci.2004.02.049","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T14:27:57Z","timestamp":1095172077000},"page":"465-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":246,"title":["Chronic urticaria: Pathogenesis and treatment"],"prefix":"10.1016","volume":"114","author":[{"given":"Allen P.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2004.02.049_BIB1","series-title":"Allergy: principles and practice","first-page":"1537","article-title":"Urticaria and angioedema","author":"Kaplan","year":"2003"},{"key":"10.1016\/j.jaci.2004.02.049_BIB2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mai.2000.105706","article-title":"Chronic urticaria","volume":"105","author":"Greaves","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1023\/A:1018851623109","article-title":"Beneficial effects of Helicobacter pylori eradication on chronic idiopathic urticaria","volume":"43","author":"DiCampli","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2004.02.049_BIB4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000023958","article-title":"Prevalence of Helicobacter pylori associated gastritis in chronic urticaria","volume":"116","author":"Wedi","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-4362.1998.00328.x","article-title":"Etiological aspects of chronic urticaria","volume":"37","author":"Liutu","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s001050050846","article-title":"Remission ration of chronic urticaria: \u201cspontaneous\u201d healing as result of eradication of Helicobacter pylori?","volume":"49","author":"Becker","year":"1998","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaci.2004.02.049_BIB7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/000155598442746","article-title":"Chronic urticaria and Helicobacter pylori","volume":"78","author":"Vasecchi","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000024176","article-title":"Chronic idiopathic urticaria: natural cause and association with H. pylori infection","volume":"119","author":"Schuyder","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000049508","article-title":"The effect of heat-inactivated Helicobacter pylori in the blastogenic response of peripheral blood mononuclear cells of patients with chronic urticaria","volume":"126","author":"Hidvegi","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archderm.1983.01650320010007","article-title":"Association of chronic urticaria and angioedema with thyroid autoimmunity","volume":"119","author":"Leznoff","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0091-6749(89)90180-2","article-title":"Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients","volume":"84","author":"Leznoff","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB12","first-page":"286","article-title":"Autoimmunity and the etiology of chronic urticaria","volume":"4","author":"Kaplan","year":"1999","journal-title":"Can J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1067\/mai.2003.1605","article-title":"Antithyroid antibodies in chronic urticaria and angioedema","volume":"112","author":"Kikuchi","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1523-1747.ep12462239","article-title":"Prevalence and functional role of anti-IgE autoantibodies in urticaria syndromes","volume":"90","author":"Gruber","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1986.tb04065.x","article-title":"A serological mediator in chronic idiopathic urticaria. A clinical, immunological, and histological evaluation","volume":"114","author":"Grattan","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.1988.tb03199.x","article-title":"Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria","volume":"119","author":"Grattan","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","article-title":"Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria","volume":"328","author":"Hide","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.02.049_BIB18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2222.1991.tb03198.x","article-title":"Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria","volume":"21","author":"Grattan","year":"1992","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2004.02.049_BIB19","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1172\/JCI118325","article-title":"Serum IgG autoantibodies directed against the a-chain of FceRI; a selection marker and pathogenetic factor for a distinct subset of chronic urticaria patients?","volume":"96","author":"Fiebiger","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.02.049_BIB20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0091-6749(96)70230-0","article-title":"Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria","volume":"98","author":"Zweiman","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0091-6749(97)70071-X","article-title":"Assessment of autoimmunity in patients with chronic urticaria","volume":"99","author":"Tong","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0091-6749(98)70176-9","article-title":"Comparative studies of functional and binding assays for IgG anti-Fc (epsilon) RI alpha (alpha subunit) in chronic urticaria","volume":"101","author":"Ferrer","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB23","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1067\/mai.2001.115484","article-title":"Mechanisms of autoimmune activation of basophils in chronic urticaria","volume":"107","author":"Kikuchi","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1034\/j.1398-9995.2003.00195.x","article-title":"IL3 effect on basophil histamine release upon stimulation with chronic urticaria sera","volume":"58","author":"Ferrer","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2004.02.049_BIB25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000066772","article-title":"Secretion of cytokines, histamine, and leukotrienes in chronic urticaria","volume":"129","author":"Ferrer","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1067\/mai.2000.104939","article-title":"Chronic urticaria serum induces histamine release, leukotrienes production, and basophil CD63 surface expression\u2014inhibitory effects of anti-inflammatory drugs","volume":"105","author":"Wedi","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB27","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1523-1747.ep12338544","article-title":"Dermal mast cell activation by autoantibody against the high affinity IgE receptor in chronic urticaria","volume":"106","author":"Niimi","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0091-6749(99)70129-6","article-title":"Complement dependence of histamine release in chronic urticaria","volume":"104","author":"Ferrer","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","article-title":"Anti-fcepsilon RIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship","volume":"101","author":"Fiebiger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.02.049_BIB30","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1096\/fj.00-0890hyp","article-title":"Conditional autoimmunity mediated by human natural anti Fc\u03b5RI\u03b1 antibodies","volume":"15","author":"Horn","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2004.02.049_BIB31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2003.09.007","article-title":"Natural anti Fc\u03b5RI\u03b1 antibodies may interfere with diagnostic tests for chronic urticaria","volume":"22","author":"Pachlopnik","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2004.02.049_BIB32","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1139::AID-IMMU1139>3.0.CO;2-J","article-title":"Human anti-FceRI\u03b1 auto-antibodies isolated from healthy donors cross react with tetanus toxoid","volume":"29","author":"Horn","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1067\/mai.2002.120954","article-title":"A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria","volume":"109","author":"Kikuchi","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0091-6749(83)90096-9","article-title":"Histologic studies of chronic idiopathic urticaria","volume":"71","author":"Natbony","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0091-6749(86)90240-X","article-title":"Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T lymphocytes, monocytes, and mast cells","volume":"78","author":"Elias","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archderm.134.1.41","article-title":"Microscopic morphology of different types of urticaria","volume":"134","author":"Haas","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0091-6749(99)70475-6","article-title":"Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-Fc-epsilon RI or anti-IgE autoantibodies","volume":"103","author":"Sabroe","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1523-1747.ep12538380","article-title":"Localization of eosinophil granule major basic protein in chronic urticaria","volume":"81","author":"Peters","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000235301","article-title":"The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions","volume":"93","author":"Gratten","year":"1990","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000023902","article-title":"Differential endothelial adhesion molecule expression in early and late whealing reactions","volume":"115","author":"Haas","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1523-1747.2002.01733.x","article-title":"Increased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria sera","volume":"118","author":"Lee","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB42","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.4049\/jimmunol.163.7.3976","volume":"163","author":"Ying","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1067\/mai.2002.126782","article-title":"Classification of anti Fc\u03b5RI and anti-IgE autoantibodies in chronic urticaria and correlation with disease activity","volume":"40","author":"Sabroe","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB44","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI108405","article-title":"Defective histamine release in chronic urticaria","volume":"57","author":"Kern","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.02.049_BIB45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0091-6749(98)70283-0","article-title":"Anti-FceRI autoantibodies and basophil histamine releasability in chronic idiopathic urticaria","volume":"102","author":"Sabroe","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB46","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-2222.1997.tb02986.x","article-title":"Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity","volume":"27","author":"Grattan","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2004.02.049_BIB47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1067\/mai.2002.121314","article-title":"Evidence for aberrant regulation of the P21 Ras pathway in PBMCCs of patients with chronic urticaria","volume":"109","author":"Confino-Cohen","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMcp011186","article-title":"Chronic urticaria and angioedema","volume":"346","author":"Kaplan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.02.049_BIB49","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.1997.tb00996.x","article-title":"Low-dose cyclosporine A is the treatment of severe chronic idiopathic urticaria","volume":"52","author":"Torbi","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2004.02.049_BIB50","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0190-9622(91)70308-O","article-title":"Oral cyclosporine for severe chronic idiopathic urticaria and angioedema","volume":"25","author":"Fradin","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized double-blind study of cyclosporine in chronic idiopathic urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB52","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.4049\/jimmunol.151.10.5563","article-title":"In vivo characterization of the anti-inflammatory effect of cyclosporine A on human basophils","volume":"151","author":"Casolmo","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB53","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/1523-1747.ep12499960","article-title":"Anti-inflmmatory effect of cyclosporin A on human skin mast cells","volume":"98","author":"Stellato","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB54","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0091-6749(84)90518-9","article-title":"The hypocomplementeric urticarial-vasculitis syndrome: therapeutic response to hydroxychoroqine","volume":"73","author":"Lopez","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1067\/mai.2003.63","article-title":"Acute and subchronic effects of levocetirizine and dephenhydromone on memory functioning, psychomotor performance, and mood","volume":"111","author":"Versten","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB56","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-132-5-200003070-00004","article-title":"Effects of fexofenadine, dephenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator","volume":"132","author":"Weiler","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2004.02.049_BIB57","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1067\/mai.2003.1408","article-title":"Sedational performance impairment of dephenhydramine and second-generation antihistaminics: a meta-analysis","volume":"111","author":"Bender","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.02.049_BIB58","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2133.1999.02767.x","article-title":"The extent and nature of disability in different urticaria conditions","volume":"140","author":"Poon","year":"1999","journal-title":"Br J Dermatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904013995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904013995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:52:48Z","timestamp":1758775968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674904013995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0091674904013995"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2004.02.049","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic urticaria: Pathogenesis and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2004.02.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}